000 | 01717 a2200481 4500 | ||
---|---|---|---|
005 | 20250516180746.0 | ||
264 | 0 | _c20161213 | |
008 | 201612s 0 0 eng d | ||
022 | _a1479-666X | ||
024 | 7 |
_a10.1016/j.surge.2013.09.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTorrance, Andrew D W | |
245 | 0 | 0 |
_aHas integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer? _h[electronic resource] |
260 |
_bThe surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland _cFeb 2015 |
||
300 |
_a19-33 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aEsophageal Neoplasms _xdiagnosis |
650 | 0 | 4 | _aEsophagectomy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorodeoxyglucose F18 _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xepidemiology |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacology |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aSurvival Rate _xtrends |
650 | 0 | 4 |
_aTomography, X-Ray Computed _xmethods |
650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
700 | 1 | _aAlmond, L Max | |
700 | 1 | _aFry, J | |
700 | 1 | _aWadley, Martin S | |
700 | 1 | _aLyburn, Iain D | |
773 | 0 |
_tThe surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland _gvol. 13 _gno. 1 _gp. 19-33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.surge.2013.09.002 _zAvailable from publisher's website |
999 |
_c23245529 _d23245529 |